Description

Natural phenolic compound Psoralidin limits cardiotoxicity associated with Doxorubicin

Disciplines

Cardiology | Cardiovascular Diseases | Cellular and Molecular Physiology | Medicinal Chemistry and Pharmaceutics | Medicine and Health Sciences | Oncology | Pharmacology | Therapeutics

Document Type

Event

Share

COinS
 

Prevention of Doxorubicin-induced cardiotoxicity by a coumestan analogue, Psoralidin

Natural phenolic compound Psoralidin limits cardiotoxicity associated with Doxorubicin